Bullpen.News From Edwin Dorsey
Get Daily Recap Feedback

Thursday, November 5, 2026

Back to the front page

AppLovin 3Q26 Business Update: No Notes

AppLovin’s Q3 revenue rose 55% year over year as AXON model gains expanded margins, while ad take-rate compression remains the key competitive risk.

APP $118B
Speedwell Research 3 clicks

From X

@aleabitoreddit

Serenity on X

To my knowledge, $CRDO doesn't have in-house CW DFB laser manufacturing capabilities, so not quite... Dustphotonics integrates external CW lasers so Credo is another potential $MRVL for the need to M&A laser companies. They did another with Hyperlume earlier but that was for microLEDs, not CW. Lot of industry channel checks like Largan cast a lot of doubts over that microLED commercialization for CPO (not every short reach application).
@ParadisLabs

Paradis on X

$LITE shareholders should be annoyed... The 23.9% premium in the $MRVL deal is real on paper, but in dollars it's gone. 1. 4.5 $MRVL per $LITE = $1,132/share on 28 Oct = 23.9% above Lumentum's undisturbed $914. This is the 23.9% premium reported today. 2. Marvell has since fallen ~22% to $196.40 (Friday close). So 4.5 shares = ~$884 = 3.3% below Lumentum’s undisturbed price of $914. 3. The deal's $102.5B equity value is now ~$80B. 4. Lumentum fell ~8% in the same selloff to the ~$840s. 5. So even vs where Lumentum actually trades, the premium has shrunk from 23.9% to ~5%. I think Marvell needs to get back above ~$203 for Lumentum shareholders to see any premiums over the undisturbed price. It's essentially a premium paid in a currency (stock) that’s fallen 22%. Welcome any pushback on my napkin math calcs. By no means a comprehensive model.
@aleabitoreddit

Serenity on X

Following the Lumentum / Marvell deal: My opinion is that independent Western laser players, like $AAOI, $COHR, and $SIVE became a lot more strategically valuable. $MTSI and $SMTC should get some attention too as emerging laser players in 2027. If I had to guess: 1. Companies competing against Marvell, or not in the $NVDA ecosystem bandwagon, such as $AMD, are likely going to rethink their relationship with $LITE. If getting bottlenecked by Nvidia capacity agreements wasn't enough... Incentives around qualifying + bringing up other laser players, seems very necessary now. Since you generally don't want competitors like Marvell to have influence or visibility over your roadmaps, IP, capacity, pricing, etc. even if there is a "firewall". 2. $MRVL acquiring Lumentum opened pandoras box in a way of acquiring a critical chokepoint all your competitors + buyers use. $LITE was used by your major hyperscalers and across AI supply chains. Now, your leaders might wonder if weaponizing capacity agreements might not be as effective.... If someone else can just buy the entire company. There's only a few major public merchant Western players out there, and I'm also sure many others will want to follow the Marvell / Broadcom route via vertical integration, given I think $MRVL saves around $1B+ in costs/year. So M&A premiums likely went up. $SMTC was actively looking to buy laser capacity via M&A so I'm sure they're looking at $SIVE given their 100M CW DFB laser expansion + tiny MC. $JBL also probably wants to vertically integrate down the road too so $SIVE is also an acquisition target for their 1.6T program. $AMD was looking for ELSFP + CW capacity given Nvidia bottlenecks, so I'm sure they've looked at $AAOI. can go on and on about other ASIC players (like in Taiwan) that likely are looking at vertical integration too. Since multiple players use a small subset of laser suppliers, if competitors just go ahead and buys them... There's a lot pressure to M&A for their own supply chain defensibility. TLDR: Independent laser suppliers should capture a material strategic revaluation since $MRVL + $LITE, sets a new precedent + implications. We'll see what happens.

Investor Letters

All letters

Trading Post November 5, 2026

MercadoLibre’s logistics expansion cut margins by 60 basis points, while Mercado Pago grew credit 62% with 7% NPLs.

MELI $77B
Cassandra Unchained 2 clicks

Intel: The CPU Comeback, Discounted

Intel's Q3 2026 results were hit by memory costs and an Israel shutdown, but enterprise AI inference could lift CPU demand as server…

INTC $287B
Monte Independent Investment Research 2 clicks

Problems at Twist Bioscience (TWST)

Twist Bioscience’s $200 rebound followed an Anthropic-linked short squeeze, yet its DNA and protein services face broad competition while…

TWST $8B
Hunterbrook 4 clicks

VSH Earnings Review

Vishay reported record Q3 revenue of $979 million, up 24%, and guided Q4 to about $990 million as rising backlog and margins contrast with…

VSH $3.6B
Cestrian Capital Research 3 clicks

Thursday Tailwinds #13: Nov 5, 2026

Florida marinas are 92% full as boat counts rise and permits constrain new supply, creating pricing power for existing operators such as…

SUI $14B
Trade Ideas Flow 6 clicks
CHWY · long

Chewy INC

Chewy (CHWY) is presented as a long opportunity after a prior 2022 short thesis played out.

CHWY $9.2B
Value Investors Club 5 clicks

Publications we follow

Every publication on this site, hand-picked.

129 publications

Newsletters 109

YouTube 4

Blogs 15

Seeking Alpha 74 of 277

Nominate a publication

X accounts we follow

Every account on this site, hand-picked.

91 accounts
Nominate an account

Investor letters we follow

359 firms

Sectors

Ordered by how often our editor reaches for them.